From Cambridge to Suzhou: a Chinese AI start-up's journey to unicorn status
In 2007, a Chinese PhD student at the University of Cambridge launched a start-up with a former classmate focused on using speech recognition technology to help foreigners learn Chinese.
A year later, Yu Kai and his team returned to China, aiming to draw on the country's vast market and deep talent pool to propel their nascent company's development.
Swapping Cambridge for Suzhou – a city in eastern China then more famous for its picturesque gardens and canals than its tech sector – may have seemed like an unconventional choice at the time, but it proved to be an inspired move.
Yu's company, AI Speech, is now riding
China's artificial intelligence boom as a leader in conversational AI. It has raised hundreds of millions of dollars over several funding rounds, with the Hurun Research Institute recognising the firm as an AI unicorn.
Its technology powers voice activation software used by carmakers Mercedes-Benz and BYD, as well as smart home brands Midea and Haier. It also develops AI chips and smart office devices like microphones and speakers.
Though the company's funding mostly comes from private investors and its own revenue, China's industrial policies have also played an important role in supporting AI Speech, according to Yu.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
4 minutes ago
- South China Morning Post
Apple supplier Lens Technology joins Hong Kong IPO boom with US$608 million deal
Hong Kong's initial public offering (IPO) boom continued on Monday as seven companies, including Apple supplier Lens Technology and chip designer Fortior, filed fresh listing applications, injecting renewed optimism into the buoyant market Precision manufacturer Lens Technology said it would raise as much as HK$4.77 billion (US$608 million) from its debut in the city, according to its stock exchange filing on Monday. The Shenzhen-listed firm is offering 262.3 million shares at HK$17.38 to HK$18.18 each. Lens Technology planned to allocate 11 per cent of the base offering to Hong Kong investors, with the remainder going to international investors. If the offer size adjustment and overallotment options were exercised, the IPO gross proceeds could swell to HK$6.3 billion at the top end of the price range. Investors can place orders from Monday to July 4, and trading was set to begin on July 9 under the stock code 6613, according to the company's proposed timetable. The company's Shenzhen-listed shares fell 0.3 per cent to 22 yuan (US$3.07) in recent trading. The offering drew cornerstone investors including Green Better, Olympic Country, UBS Asset Management Singapore and Oaktree Capital. They agreed to subscribe for about US$280 million worth of the IPO shares. Citic Securities is the sole IPO sponsor. Founded in 1993 in Shenzhen by chairwoman Chau Kwan Fei, Lens Technology is headquartered in Liuyang in China's central Hunan province, according to its website. Chau was expected to control 59.03 per cent of the company after the listing, according to the prospectus.
The Standard
9 minutes ago
- The Standard
Money comes and goes: An unexpected deposit turns a HKer into a millionaire before it flows
Money comes and goes: An unexpected deposit turns a HKer into a millionaire before it flows
South China Morning Post
an hour ago
- South China Morning Post
Can Singapore's bourse regain its allure, as more companies flock to Hong Kong for IPOs?
Hong Kong's vast lead over Singapore as a listing venue appears unassailable, with even the Southeast Asian city's home-grown companies heading north to raise funds, but the city state remains determined to improve its allure, according to bankers and analysts. IFBH, a Singapore-incorporated Thai firm that is the world's second-largest bottler of coconut water, started trading on the Hong Kong stock exchange on Monday after completing a HK$1.16 billion (US$147 million) initial public offering (IPO) . The bottler of the If brand had planned to list in Singapore but changed course and applied in Hong Kong in April, citing strong connectivity with mainland China, its most important market. IFBH's debut in the city followed that of Mirxes, a Singaporean biotechnology company that raised HK$1.09 billion and saw its shares surge 28.8 per cent on the first day of trading on May 23. The Singapore Exchange (SGX) recorded just one IPO this year, raising US$4.5 million, while the Hong Kong stock exchange raised US$13.2 billion through 38 deals, according to data from the London Stock Exchange Group. Last year, SGX had four deals totalling US$34.2 million, compared with Hong Kong's US$11.3 billion from 67 deals. IFBH and Mirxes underline the valuation upside and deep liquidity in Hong Kong's stock market, which has a market capitalisation of US$6.5 trillion – up 37 per cent from a low point last September – and a daily trading volume of around US$30 billion. Meanwhile, Singapore's stock market is worth about US$488 billion and has a daily trading volume of about US$1.1 billion. Despite US-China trade tensions driving some Chinese firms to expand in Southeast Asia and consider listings in Singapore, analysts said the impact on Hong Kong's appeal as a listing venue remained minimal.
